Indication
Metastatic urothelial carcinoma
Metastatic urothelial carcinoma is an advanced malignancy arising from the specialized transitional epithelium that lines the urinary tract, most frequently originating in the urinary bladder, ureters, or renal pelvis. Read more about Metastatic urothelial carcinoma
0 drugs 0 manufacturers
Drugs that treat it
Common Metastatic urothelial carcinoma therapies.
No drugs are available
This indication does not currently contain public drugs.
News & literature
Coming soonRelated codes
Coming soonRelated conditions & guidelines
Coming soonMetastatic urothelial carcinoma is an advanced malignancy arising from the specialized transitional epithelium that lines the urinary tract, most frequently originating in the urinary bladder, ureters, or renal pelvis.
It predominantly affects older adults, occurring with higher incidence in males and individuals with a history of tobacco exposure.
Pathophysiologically, the disease is defined by primary malignant cells invading deep muscular layers and disseminating through vascular or lymphatic channels to distant anatomical sites, commonly including non-regional lymph nodes, the lungs, liver, and bones.
Clinically, it presents with hematuria, flank or pelvic pain, and systemic manifestations corresponding to the burden and distribution of secondary metastatic lesions.
- nih.gov
Metastatic urothelial carcinoma is an advanced malignancy arising from the specialized transitional epithelium that lines the urinary tract, most frequently originating in the urinary bladder, ureters, or renal pelvis It predominantly affects older adults, occurring with higher incidence in males and individuals with a history of tobacco exposure
- mdanderson.org
Metastatic urothelial carcinoma is an advanced malignancy arising from the specialized transitional epithelium that lines the urinary tract, most frequently originating in the urinary bladder, ureters, or renal pelvis
- clevelandclinic.org
Metastatic urothelial carcinoma is an advanced malignancy arising from the specialized transitional epithelium that lines the urinary tract, most frequently originating in the urinary bladder, ureters, or renal pelvis
- nih.gov
It predominantly affects older adults, occurring with higher incidence in males and individuals with a history of tobacco exposure
- nih.gov
Pathophysiologically, the disease is defined by primary malignant cells invading deep muscular layers and disseminating through vascular or lymphatic channels to distant anatomical sites, commonly including non-regional lymph nodes, the lungs, liver, and bones Clinically, it presents with hematuria, flank or pelvic pain, and systemic manifestations corresponding to the burden and distribution of secondary metastatic lesions
- nih.gov
Pathophysiologically, the disease is defined by primary malignant cells invading deep muscular layers and disseminating through vascular or lymphatic channels to distant anatomical sites, commonly including non-regional lymph nodes, the lungs, liver, and bones
Personalize your experience
Follow Metastatic urothelial carcinoma and get updates as they land.
Already a member? Sign in
Follow an indication and get alerts when its drugs, labels, or guidelines change
Save any drug on this page to your favorites, synced across devices
AI-curated peer-reviewed research, summarized for your specialty
A morning digest of indication-relevant updates, when you want it
Sign in to follow this indication
Following an indication requires a free Physicians Office Resource account.